Comparison of Oxidative Stress Markers in Type 2 Diabetes: Basal Bolus Therapy versus Twice Daily Premixed Insulin Analogs

被引：3
|
作者：
Sakamoto, Masaki [1 ,2 ]
Inoue, Gaku [1 ,2 ]
Tsuyusaki, Kaoru [2 ]
Usui, Kensuke [2 ]
Watanabe, Miwako [3 ]
Irie, Junichiro [1 ,4 ]
Atsuda, Koichiro [2 ]
Yamada, Satoru [1 ,4 ]
机构：
[1] Kitasato Inst Hosp, Ctr Diabet, Tokyo, Japan
[2] Kitasato Univ, Sch Pharmaceut Sci, Dept Hosp Pharm, Tokyo 108, Japan
[3] Mareesia Garden Clin, Tokyo, Japan
[4] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan
来源：
INTERNAL MEDICINE | 2010年 / 49卷 / 05期
关键词：
oxidative stress; insulin therapy; diabetes; POSTPRANDIAL HYPERGLYCEMIA; DAILY INJECTIONS; COMPLICATIONS; HYPERINSULINEMIA; PREVALENCE; MELLITUS;
D O I：
10.2169/internalmedicine.49.2725
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Aims Several studies have shown that twice-daily injection of premixed insulin analog (MIX) therapy achieves glycemic control equivalent to that with basal-bolus (BB) therapy. However, glycemic fluctuations that lead to oxidative stress may be associated with the risk of diabetic complications. Therefore, in this study, we compared oxidative stress markers between MIX therapy and BB therapy. Methods In this cross-sectional study, we recruited a total of 37 patients (17 patients in the BB group and 20 patients in the MIX group) and compared urinary 8-isoprostane and urinary 8-hydroxydeoxyguanosine (8-OHdG) levels. Results There were no significant differences in urinary 8-isoprostane (BB vs MIX: 199 +/- 92 pg/mg Cr vs 266 +/- 107 pg/mg Cr) or urinary 8-OHdG (4.7 +/- 1.6 ng/mg Cr vs 5.4 +/- 1.9 ng/mg Cr, respectively). Conclusion These results suggest that MIX is equivalent to BB in terms of glycemic fluctuations and oxidative stress.
引用
收藏
页码：355 / 359
页数：5
相关论文
共 50 条
  • [1] Insulin therapy for type 2 diabetes: premixed or basal-prandial?
    Halbron, M.
    Jacqueminet, S.
    Sachon, C.
    Bosquet, F.
    Hartemann-Heurtier, A.
    Grimaldi, A.
    DIABETES & METABOLISM, 2007, 33 (04) : 316 - 320
  • [2] Comparison of a twice daily injection of insulin aspart 50 with insulin aspart 30 in patients with poorly controlled type 2 diabetes
    Shi, Chunhong
    Sun, Luyan
    Bai, Ran
    Wang, Hao
    Liu, Dan
    Du, Jianling
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (06) : 1091 - 1096
  • [3] Effects of Twice-Daily Injections of Premixed Insulin Analog on Glycemic Control in Type 2 Diabetic Patients
    Shimizu, Hiroaki
    Monden, Tsuyoshi
    Matsumura, Mihoko
    Domeki, Nozomi
    Kasai, Kikuo
    YONSEI MEDICAL JOURNAL, 2010, 51 (06) : 845 - 849
  • [4] Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial
    Jia, Weiping
    Xiao, Xinhua
    Ji, Qiuhe
    Ahn, Kyu-Jeung
    Chuang, Lee-Ming
    Bao, Yuqian
    Pang, Can
    Chen, Lei
    Gao, Fei
    Tu, Yinfang
    Li, Pengfei
    Yang, Jun
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (04) : 254 - 262
  • [5] Comparison of twice-daily injections of biphasic insulin lispro and basal-bolus therapy: glycaemic control and quality-of-life of insulin-naive type 2 diabetic patients
    Masuda, H.
    Sakamoto, M.
    Irie, J.
    Kitaoka, A.
    Shiono, K.
    Inoue, G.
    Atsuda, K.
    Yamada, S.
    DIABETES OBESITY & METABOLISM, 2008, 10 (12) : 1261 - 1265
  • [6] Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Giugliano, Dario
    Chiodini, Paolo
    Maiorino, Maria Ida
    Bellastella, Giuseppe
    Esposito, Katherine
    ENDOCRINE, 2016, 51 (03) : 417 - 428
  • [7] Comparison of insulin lispro protamine suspension and insulin detemir in basal-bolus therapy in patients with Type 1 diabetes
    Chacra, A. R.
    Kipnes, M.
    Ilag, L. L.
    Sarwat, S.
    Giaconia, J.
    Chan, J.
    DIABETIC MEDICINE, 2010, 27 (05) : 563 - 569
  • [8] The Effect of Type and Daily Doses of Insulin to Treatment Success in Type 2 Diabetes Patients who are Receiving Basal-bolus Insulin Therapy
    Ozturkmen, Yuksel Asli
    Avci, Suna
    Calim, Aslihan
    Cetin, Elif Guven
    Demir, Nazan
    Mazi, Emrah Erkan
    Borlu, Fatih
    Altuntas, Yuksel
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2020, 54 (04): : 416 - 423
  • [9] Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study
    Fritsche, A.
    Larbig, M.
    Owens, D.
    Haering, H.-U.
    DIABETES OBESITY & METABOLISM, 2010, 12 (02) : 115 - 123
  • [10] TWICE DAILY INSULIN THERAPY IN PATIENTS WITH TYPE-2 DIABETES AND SECONDARY FAILURE TO SULFONYLUREAS
    WOLFFENBUTTEL, BHR
    WEBER, RFA
    WEEKS, L
    VANKOETSVELD, PM
    VERSCHOOR, L
    DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 1990, 13 (02): : 79 - 84
12345